Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2021

View Archived Issues

First clinical data presented for BNT-211 in patients with CLDN6-positive solid tumors

Phase I dose-escalation study tests combination immunotherapy with belapectin and pembrolizumab

Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer

Ono Pharmaceutical, Vanderbilt University present KCNT1/KCNK2 blockers

ReViral synthesizes new benzodiazepine derivatives

New anti-HBV compounds identified at Sunshine Lake Pharma

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

ShanghaiTech University, Fudan University patent new PROTACs

New Angex Pharmaceutical anticancer compounds show preclinical potential

Full-data analysis from 12-month treatment phase of ALTISSIMO study in wet AMD

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

New phase II trial evaluates CBP-201 for moderate to severe persistent asthma

Mitsubishi Tanabe discontinues development of MT-5745 for ulcerative colitis

Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802

Mabwell initiates first-in-human study of 9MW-1411

China's NMPA issues clinical trial approval for JS-103 for gout

Preclinical characterization of novel 3CL(pro) inhibitors against COVID-19

Clene Nanomedicine presents preliminary phase II data for CNM-Au8 in ALS

HU-6 enters phase II development as potential treatment of NASH

OCS-02 shows safety and efficacy in phase II study in patients with acute anterior uveitis

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

Xilio presents preclinical data on tumor-selective anti-CTLA-4 antibody XTX-101

AzurRx reports phase II interim data on MS-1819 for severe exocrine pancreatic insufficiency

Engineering blood cells can treat brain diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...